tailieunhanh - Ebook FRCR 2B Viva-A case-based approach: Part 1

(BQ) Part 1 book "FRCR 2B Viva-A case-based approach" presents the following contents: Gastrointestinal imaging, chest imaging, musculoskeletal imaging. Invite you to consult. | FRCR 2B Viva A Case-Based Approach Paul s. Sidhu Suzanne M. Ryan Phillip E c. Lung Thieme FRCR 2B Viva A Case-Based Approach Paul S. Sidhu BSc Hons. MBBS Hons. MRCP FRCR DTM H Professor of Imaging Sciences King s College London Consultant Radiologist King s College Hospital Denmark Hill London United Kingdom Suzanne M. Ryan MRCPI FRCR Consultant Gastrointestinal and Abdominal Radiologist King s College Hospital Denmark Hill London United Kingdom Phillip F. C. Lung BSc Hons. MBBS MRCS FRCR Subspeciality Fellow in Gastrointestinal Radiology King s College Hospital Denmark Hill London United Kingdom 409 illustrations Thieme Stuttgart New York Library of Congress Cataloging-in-Publication Data is available from the publisher. Important note Medicine is an ever-changing science undergoing continual development. Research and clinical experience are continually expanding our knowledge in particular our knowledge of proper treatment and drug therapy. Insofar as this book mentions any dosage or application readers may rest assured that the authors editors and publishers have made every effort to ensure that such references are in accordance with the state of knowledge at the time of production of the book. Nevertheless this does not involve imply or express any guarantee or responsibility on the part of the publishers in respect to any dosage instructions and forms of applications stated in the book. Every user is requested to examine carefully the manufacturers leaflets accompanying each drug and to check if necessary in consultation with a physician or specialist whether the dosage schedules mentioned therein or the contraindications stated by the manufacturers differ from the statements made in the present book. Such examination is particularly important with drugs that are either rarely used or have been newly released on the market. Every dosage schedule or every form of application used is entirely at the user s owwn risk and responsibility. The authors and publishers